BackEuropean Biotech Acquisition Overview

European Biotech Acquisition Common Stock

Track European Biotech Acquisition's common stock ($130M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$129.26M

Peer average

Loading

European Biotech Acquisition Common Stock History

Loading

European Biotech Acquisition vs. peers: Common Stock Comparison

Loading

European Biotech Acquisition Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

European Biotech Acquisition (EBAC) FAQ

As of the most recent data (December 2022), EBAC shows a common stock of $130M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBAC's common stock is now $130M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition is outperforming or lagging.

Tracking EBAC's common stock over time shows whether European Biotech Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $130M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has European Biotech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $130M) with ownership activity and broader fundamentals.